Vertical: CNMBase Year: 2025
Market Size (2025)
$100.91M
Projected (2032)
$132.05M
CAGR (2022–2032)
3.9%
Key Players
10+
Market Overview
The Global L-Lysine Sulfate Market was valued at USD 100.91 Million in 2025 and is projected to reach USD 132.05 Million by 2032, registering a CAGR of 3.92% over the forecast period 2026–2032. The market has grown steadily from USD 89.90 Million in 2022 and USD 97.10 Million in 2024, and is expected to add USD 31.14 Million in absolute value between 2025 and 2032.
L-lysine sulfate is a fermentation-derived, feed-grade source of L-lysine, the first limiting amino acid in most swine diets and a key limiting amino acid in poultry diets. Because the product is manufactured by granulating or drying the fermentation broth rather than by crystallising pure lysine hydrochloride, it delivers lysine at a lower cost per unit and retains part of the fermentation biomass. Demand is therefore closely linked to compound feed output, to the economics of soybean meal and other protein ingredients, and to the progressive adoption of low-crude-protein, amino-acid-balanced feeding programmes.
Key Findings
By Livestock: Swine is the largest segment, with USD 55.50 Million and a 55.0% share in 2025. Others is the fastest-growing segment at a CAGR of 4.82%, while Poultry, the second-largest segment, grows at 4.49%.
By Physical Form: Granules is both the largest segment, with USD 90.82 Million and a 90.0% share in 2025, and the fastest-growing segment, at a CAGR of 4.04%.
By Region: Asia Pacific is the leading region, valued at USD 42.38 Million (42.0% share) in 2025. Middle East & Africa is the fastest-growing region, with a CAGR of 4.89%.
By Country: China is the leading country, valued at USD 22.04 Million in 2025, equivalent to 21.8% of the global market. India is the fastest-growing country, with a CAGR of 5.89%.
Segmentation Summary
The market is analysed by livestock (Swine, Poultry and Others), by physical form (Granules and Others) and by region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), with country-level coverage within each region. Swine diets remain the anchor of demand, reflecting the high lysine requirement of growing pigs and the scale of commercial pig production in China, Europe and North America. Poultry is gaining share, from 40.0% in 2025 to 41.6% in 2032, supported by the continued expansion of broiler production in Asia Pacific, Latin America and the Middle East & Africa. Granular product dominates because granulation improves flowability, reduces dust and enables accurate dosing in feed mills; its share rises from 90.0% in 2025 to 90.8% in 2032.
Competitive Landscape Summary
Supply is concentrated in China, which accounted for 79.6% of global lysine production capacity in 2025 according to Chinese industry data. Large Chinese producers such as Meihua Holdings Group, Guangdong Xinghu Technology (through Eppen Biotech) and Fufeng Group compete on scale and cost, while CJ CheilJedang and Evonik Industries operate fermentation assets outside China, including in the United States and Brazil. Trade remedies have become a defining feature of competition: the European Union imposed definitive anti-dumping duties on Chinese lysine in July 2025, the United States issued anti-dumping and countervailing duty orders covering L-lysine, including lysine sulfate, in September 2026, and Brazil applied a definitive anti-dumping duty on Chinese lysine in June 2026.
Challenges and Opportunities
Key challenges include volatility in corn, sugar and energy costs, which drive fermentation economics; price competition from lysine hydrochloride when its price falls, as occurred in China in 2025; and the operational complexity of formulating with a lower-concentration lysine source. Opportunities arise from the regionalisation of supply behind trade barriers, from higher-concentration and nutritionally enriched product grades, and from strong poultry growth in South Asia, the Middle East and Africa, where commercial feed penetration is still rising.
Future Outlook
Over 2026–2032, the market is expected to expand at a CAGR of 3.92%, with growth led by Asia Pacific, Latin America and Middle East & Africa. Low-protein diet adoption, national programmes to reduce soybean meal use in feed, and tighter nitrogen-emission rules for livestock operations are expected to support steady growth in amino acid inclusion. Market value growth will, however, be moderated by price competition as new fermentation capacity comes on stream, and by the redistribution of trade flows caused by the duties introduced in 2025–2026.
The L-Lysine Sulfate Market market is projected to grow at a CAGR of 3.9% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
L-lysine sulfate (CAS No. 60343-69-3) is a feed additive that supplies the essential amino acid L-lysine to livestock and poultry. It is produced by aerobic fermentation of carbohydrate feedstocks, typically corn-derived dextrose, sugar or molasses, using bacterial strains such as Corynebacterium glutamicum. The lysine formed during fermentation is neutralised with sulphate, and the broth, including part of the bacterial biomass, is concentrated and then granulated or dried. The resulting product, commonly traded in China as "70% lysine", contains a lower lysine content than L-lysine hydrochloride ("98% lysine") but provides lysine at a lower cost per unit along with residual nutrients from the fermentation process.
Included in the scope: feed-grade L-lysine sulfate products of fermentation origin in granular and other physical forms, sold to compound feed manufacturers, premix and concentrate producers, integrated livestock producers and on-farm mixers for use in swine, poultry and other animal diets.
Excluded from the scope: L-lysine monohydrochloride, liquid lysine, food-grade and pharmaceutical-grade lysine, other feed amino acids (such as methionine, threonine, tryptophan and valine), and complete feeds or premixes valued at the finished-feed level.
Scope of the Study
Countries: U.S., Canada, Mexico; Germany, U.K., France, Italy, Spain, Rest of Europe; China, India, Japan, Rest of Asia Pacific; Brazil, Argentina, Rest of Latin America; UAE, Saudi Arabia, South Africa, Rest of MEA
Timeline: historic years 2022–2024, base year 2025, forecast period 2026–2032
Currency/Unit: USD Million
Research Objectives
To estimate the size of the Global L-Lysine Sulfate Market for 2022–2025 and forecast it for 2026–2032 in USD Million.
To analyse the market by livestock and physical form, and to identify the largest and fastest-growing segments.
To assess regional and country-level demand patterns across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To evaluate the drivers, restraints, opportunities and trends that shape L-lysine sulfate demand, including low-protein diet adoption and soybean meal reduction policies.
To examine the effect of feedstock costs, fermentation capacity additions and trade remedies on pricing and supply.
To analyse the value chain, competitive intensity and regulatory framework governing feed amino acids.
To profile the competitive positioning and key developments of leading L-lysine sulfate producers.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process. It begins with defining the market scope and segmentation, followed by extensive secondary research to build an understanding of feed amino acid supply, livestock production and feed demand. Primary research with industry participants is then used to validate assumptions, refine estimates and capture qualitative insights. Market sizes are derived through complementary top-down and bottom-up approaches, triangulated against independent data points, and projected over the forecast period using a factor-based forecasting model.
Stage 1 – Scoping: definition of the product, inclusions and exclusions, segmentation and geographic coverage.
Stage 2 – Secondary research: compilation of production, trade, price and regulatory data relevant to feed-grade lysine.
Stage 3 – Primary research: discussions with supply-side and demand-side participants to validate data and assumptions.
Stage 4 – Market estimation: top-down and bottom-up sizing, followed by data triangulation.
Stage 5 – Forecasting and validation: projection of market values for 2026–2032 and final consistency checks.
Secondary Research
Secondary research drew on sources specific to the feed additives and livestock industries, including:
Industry associations: national and regional feed manufacturers' associations, feed additive industry bodies, and pork and poultry producer associations, which publish feed output, livestock inventory and industry outlook data.
Government and regulatory bodies: agriculture ministries and statistical agencies (for example, livestock and feed statistics from the USDA, the European Commission and China's Ministry of Agriculture and Rural Affairs), feed additive authorisation registers and food safety authorities, and trade remedy authorities whose investigation records contain detailed data on lysine production, capacity, imports and pricing.
Company filings: annual reports, investor presentations and stock exchange disclosures of amino acid producers and their parent groups.
Trade journals and industry publications: feed industry and animal nutrition publications covering capacity announcements, prices and regulatory developments.
Trade and paid databases: customs and trade statistics by tariff line, commodity price databases for corn, sugar and soybean meal, and proprietary company and market databases.
Primary Research
Primary research was conducted through in-depth interviews and structured discussions with participants across the value chain. The objectives were to validate the market sizes derived from secondary research, understand product-form preferences and inclusion practices, capture pricing dynamics, and obtain views on the outlook for demand and supply.
Supply-side respondents: executives and managers at lysine producers, product managers for feed amino acids, distributors and traders of feed additives, and fermentation technology specialists.
Demand-side respondents: nutritionists and procurement managers at compound feed mills, premix manufacturers and integrated swine and poultry producers, as well as animal nutrition consultants.
Discussion themes: consumption volumes, lysine sulfate versus lysine hydrochloride usage, form preferences, price trends, supplier selection criteria, and the impact of trade measures and regulations.
Market Size Estimation
Top-down approach: the global feed lysine market was estimated from lysine production, trade and consumption data. The share of lysine consumed in sulfate form was then derived by region based on producer output mix, trade flows by product type and feed-industry usage patterns, and allocated across livestock and physical-form segments.
Bottom-up approach: demand was built up from compound feed production by species and country, average lysine inclusion requirements, the proportion of supplemental lysine supplied as lysine sulfate, and average realised prices by region. Country-level estimates were aggregated to regional and global totals.
Data triangulation: results from both approaches were compared and reconciled with supply-side indicators such as producer capacity and sales volumes, trade statistics and pricing data. Discrepancies were resolved through additional primary interviews before finalising the estimates.
Forecasting Methodology
Forecasts were developed using a factor-based model that links market value to underlying demand and price drivers. Factors considered include:
Projected growth in swine, poultry and other livestock production and compound feed output by country.
Adoption of low-crude-protein diets and policies to reduce soybean meal use in feed.
Relative pricing of lysine sulfate, lysine hydrochloride and protein meals.
Feedstock and energy cost trends affecting fermentation economics.
Capacity additions, trade remedies and changes in trade flows.
Regulatory developments affecting feed additives and livestock operations.
Each factor was assessed for its expected impact over the short, medium and long term, and the resulting growth rates were applied to the base-year estimates. The forecasts were validated with industry participants.
Base Year, Forecast Period and Currency
Assumptions and Limitations
Market values are expressed in nominal USD Million; fluctuations in exchange rates are not modelled separately.
No major disruption beyond those already known, such as large-scale animal disease outbreaks, is assumed during the forecast period.
Trade remedies in force at the time of the study are assumed to remain in place for their stated duration.
Prices are assumed to follow underlying feedstock and supply-demand trends without extreme volatility.
Country-level data for some emerging markets relies on estimates where official statistics on feed additive use are limited.
The analysis is limited to feed-grade L-lysine sulfate and does not value other lysine forms except as substitutes.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global L-Lysine Sulfate Market is moderately consolidated at the producer level, with a limited number of large fermentation companies supplying most of the world's feed-grade lysine, and fragmented at the distribution level, where numerous traders and distributors serve small and medium feed mills. Production capacity is concentrated in China, which accounted for 79.6% of global lysine capacity in 2025 according to Chinese industry data. Large Chinese producers integrated with corn processing compete primarily on cost and scale, while CJ CheilJedang and Evonik Industries compete through multi-regional production networks, technical service and branded products.
Competition is primarily price-based because lysine sulfate is a standardised product. Producers differentiate through lysine concentration, granule quality, supply reliability, regional logistics and technical support. Trade remedies introduced in 2025–2026 have become an important competitive factor, giving producers with plants in the European Union, the United States and Brazil an advantage in those markets while intensifying competition in regions without duties.
Key Player Positioning
Leaders: Meihua Holdings Group, Guangdong Xinghu Technology (Eppen Biotech), Fufeng Group, CJ CheilJedang and Evonik Industries form the leading group. Meihua, China's largest lysine producer, reported operating revenue of RMB 24.21 billion for FY2025 and operates a 300,000-tonne lysine facility in Jilin that began with 70% lysine output. Fufeng Group reported FY2025 revenue of RMB 27.88 billion, with lysine sales volume rising 30.4% to 435,140 tonnes. Guangdong Xinghu Technology, which acquired Eppen Biotech in 2022, reported FY2025 revenue of RMB 15.90 billion. CJ CheilJedang reported FY2025 revenue of KRW 17.75 trillion excluding CJ Logistics, including KRW 3.96 trillion from its bio business, and decided in April 2025 to retain and expand that business after ending a sale process. Evonik, which reported FY2025 group sales of EUR 14.1 billion, markets Biolys, a granular L-lysine sulfate-based product made in Blair, Nebraska, and Castro, Brazil.
Challengers: Shouguang Golden Corn Development and Heilongjiang Chengfu Food Group are among the larger Chinese lysine producers by capacity and compete actively in domestic and export markets for feed-grade lysine.
Niche players: Eurolysine (Avril Group), the only lysine producer in the European Union, holds a protected regional position following the EU anti-dumping duties of 2025. Zhucheng Dongxiao Biotechnology, which offers L-lysine sulfate 70%, and Heilongjiang Wanli Runda Biotechnology are mid-sized Chinese producers with a focus on price-competitive feed-grade lysine.
Bargaining Power of Suppliers – Medium
Corn, sugar and energy are widely traded commodities with many suppliers, limiting the leverage of any individual supplier.
Producers integrated with corn processing reduce their dependence on external feedstock suppliers.
Suppliers of proprietary strains and fermentation technology hold some influence, but most large producers develop strains in-house.
Bargaining Power of Buyers – High
Large feed manufacturers and integrators buy in high volumes and negotiate on price per unit of lysine.
Buyers can switch between lysine sulfate, lysine hydrochloride and liquid lysine, and between suppliers, with limited switching costs.
Transparent commodity-style pricing, especially in China, strengthens buyers' negotiating position.
Threat of Substitutes – High
Lysine hydrochloride and liquid lysine are direct substitutes, and their relative prices determine form selection.
Higher inclusion of protein meals such as soybean meal can partly replace synthetic lysine when amino acid prices rise.
Threat of New Entrants – Low
Fermentation plants require high capital investment and large scale to be cost competitive.
Strain technology, process know-how and access to low-cost feedstock are significant entry barriers.
Feed additive authorisation requirements in major markets add time and cost for new suppliers.
Intensity of Competitive Rivalry – High
Capacity additions, especially in China, have created periods of oversupply and price competition.
Products are largely standardised, making price the main competitive lever.
Trade remedies are intensifying competition in markets without duties as exports are redirected.
Bargaining power of suppliers: Medium; Commodity feedstocks with many suppliers; backward integration by large producers.
Bargaining power of buyers: High; Large, price-sensitive buyers able to switch forms and suppliers.
Threat of substitutes: High; Lysine HCl, liquid lysine and protein meals.
Threat of new entrants: Low; High capital needs, strain technology and regulatory approvals.
Competitive rivalry: High; Capacity additions, standardised products and trade-driven price pressure.
Market estimates by geography (2032)
InsightAsia Pacific leads with $56.69M by 2032, while Middle East & Africa is projected to grow fastest at a 4.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $16.50M | $19.34M | $22.67M | 3.2% | 17% |
| Europe | $16.55M | $19.30M | $22.50M | 3.1% | 17% |
| Asia Pacific | $37.41M | $46.08M | $56.69M | 4.2% | 43% |
| Latin America | $14.21M | $17.59M | $21.72M | 4.3% | 16% |
| Middle East & Africa | $5.24M | $6.68M | $8.47M | 4.9% | 6% |
| Total | $89.90M | $108.98M | $132.05M | 3.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$132.05M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Swine | $70.09M | 3.4% | 53% |
| Poultry | $54.93M | 4.5% | 42% |
| Others | $7.03M | 4.9% | 5% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on L-Lysine Sulfate Market covering market dynamics, competitive landscape, and strategic outlook.
The L-Lysine Sulfate Market market is projected to reach $132.05M by 2032, growing at 3.9% CAGR. The Swine segment holds the largest share.
The L-lysine sulfate market is shaped by the interplay between livestock production, feed formulation practices, fermentation economics and trade policy. Demand rises with compound feed output and with the substitution of synthetic amino acids for intact protein in diets. Supply is shaped by fermentation capacity, which is heavily concentrated in China, and by feedstock and energy costs. Since 2025, trade remedies in the European Union, the United States and Brazil have added a policy dimension that is redrawing regional supply patterns. This chapter evaluates the major growth factors, drivers, restraints, opportunities, trends and challenges affecting the market over 2026–2032.
Market Growth Factor Analysis
The table below summarises five macro and five micro factors influencing the market. Each factor is classified by impact type (promoting, inhibiting or steady) and assigned an impact score out of 10 for three forecast sub-periods. The scores are analyst assessments based on the secondary and primary research conducted for this study, where a higher score indicates a stronger influence on market growth.
Rising Global Demand for Animal Protein
Population growth, urbanisation and rising incomes continue to lift consumption of pork, poultry meat and eggs, particularly in Asia, Latin America and Africa. Higher meat output requires more compound feed, and every tonne of balanced swine or poultry feed requires supplemental lysine because cereal-based diets are naturally deficient in this amino acid. Poultry is the fastest-expanding meat category globally because of its short production cycle, efficient feed conversion and broad cultural acceptance, which explains why the Poultry segment of this market grows at a CAGR of 4.49% against 3.40% for Swine. Large-scale producers in Brazil, the United States, China and Thailand are continuing to invest in integrated broiler and pig operations, where nutritionists formulate diets on a digestible amino acid basis and routinely use synthetic lysine. As livestock production in emerging markets shifts from backyard systems to commercial farms that use manufactured feed, the base of lysine users expands. This structural shift is a central reason why Asia Pacific, Latin America and Middle East & Africa all grow faster than the global average of 3.92%.
Shift to Low-Protein Diets and Reduced Soybean Meal Use
Feeding diets with lower crude protein, balanced with synthetic amino acids, has become a mainstream strategy to reduce feed costs, improve gut health and cut nitrogen excretion. Lysine is the first amino acid added in such programmes. China's Ministry of Agriculture and Rural Affairs launched a three-year action plan in 2023 to reduce and substitute soybean meal in feed, which targeted a lower share of soybean meal in compound feed by 2025, and this policy direction continues to encourage the use of amino acids such as lysine, threonine and valine. In Europe, nitrogen and ammonia emission rules under the Nitrates Directive and national manure regulations give pig and poultry producers an additional incentive to formulate low-protein diets. Because L-lysine sulfate supplies lysine at a lower cost per unit than lysine hydrochloride, it is well suited to these cost-focused reformulations, particularly in high-volume swine and broiler feeds. As nutritionists add threonine, valine and other amino acids to push crude protein levels lower, the lysine requirement is increasingly met from synthetic sources rather than from soybean meal, which structurally lifts lysine demand per tonne of feed.
Cost Efficiency of Lysine Sulfate
L-lysine sulfate is manufactured with fewer downstream purification steps than lysine hydrochloride because the fermentation broth is granulated with much of its biomass, rather than crystallised. This reduces processing cost and yield losses, and allows the product to carry additional nutrients and energy from the fermentation biomass. The cost gap is visible in market prices: according to Chinese industry data, the average 2025 market price of 70% lysine in China was CNY 4,969 per tonne, against about CNY 7,949 per tonne for 98% lysine. Feed formulators who value lysine on a per-unit basis therefore frequently choose the sulfate form for bulk feeds. Producers have also improved product concentration; for example, Evonik raised the lysine content of its Biolys product to 62.4% in June 2023 from 60% previously, improving its competitiveness against hydrochloride in freight-sensitive markets. In addition, the inclusion of biomass means that lysine sulfate contributes some energy and other amino acids to the diet, which nutritionists can credit in least-cost formulation. For large integrators producing hundreds of thousands of tonnes of feed a year, even small savings per tonne translate into material cost reductions, which sustains the preference for the sulfate form in bulk grower and finisher diets.
Industrialisation of the Feed Sector in Emerging Markets
Commercial feed production is expanding rapidly in India, Southeast Asia, the Middle East and Africa as poultry and pig production consolidates into larger, more professionally managed operations. Integrated poultry companies in India, Saudi Arabia and South Africa use formulated feeds with defined amino acid specifications, increasing demand for supplemental lysine. Saudi Arabia's food security agenda has supported investment in domestic poultry production, while India's broiler industry has grown on the back of integrator-led contract farming. These developments are reflected in the market data: India is the fastest-growing country at a CAGR of 5.89%, and Middle East & Africa is the fastest-growing region at 4.89%. Rising feed mill capacity and improving nutritional know-how in these markets are expected to sustain above-average growth throughout the forecast period. International feed additive suppliers and distributors are also expanding technical service teams in these regions, helping smaller feed mills adopt amino acid-balanced formulations, while the availability of competitively priced lysine from Chinese producers, increasingly redirected away from markets with trade remedies, lowers the cost barrier to adoption.
Regional Production Behind Trade Barriers
The trade measures adopted in the European Union, the United States and Brazil create opportunities for producers with fermentation assets inside these markets. In Europe, Eurolysine, the region's only lysine producer, has announced a plan to increase production capacity by 20% by 2027 as part of a five-year investment programme. In the Americas, producers with plants in the United States and Brazil are positioned to capture demand previously served by imports. Over the forecast period, new or expanded local capacity, including sulfate-form lines that offer cost advantages for domestic feed mills, could gain share in these regions.
Poultry Growth in South Asia, the Middle East and Africa
Poultry production in India, Saudi Arabia, South Africa and the wider Middle East & Africa region is expanding faster than the global average, and these markets still have room to increase the use of formulated feeds and synthetic amino acids. Poultry is the largest livestock segment in Middle East & Africa, with a 78.0% share in 2025, and in India, where it accounts for 86.0% of the market. Suppliers that build distribution networks, technical service capabilities and local inventories in these markets can benefit from rising adoption.
Product Innovation and Sustainability Positioning
Producers can differentiate L-lysine sulfate through higher lysine concentrations, improved granule quality and documented nutritional contributions from the fermentation biomass. Sustainability is another lever: feed manufacturers and retailers increasingly request lifecycle assessments and carbon footprint data for feed ingredients, and the reduced processing of sulfate-form lysine, combined with its role in cutting nitrogen excretion through low-protein diets, can support sustainability claims. Products backed by verified environmental data are well placed to win business with large integrators that have set emission-reduction targets.
Volatility in Feedstock and Energy Costs
Fermentation-based lysine production depends on carbohydrate feedstocks such as corn-derived dextrose, sugar or molasses, and on substantial energy inputs for fermentation, evaporation and granulation. Fluctuations in corn and energy prices therefore translate directly into production costs. When feedstock costs rise faster than lysine prices, producer margins are compressed and capacity utilisation may be cut; when costs fall, the resulting price declines reduce market value even if volumes grow. In 2025, lower raw material costs contributed to lower lysine selling prices in China, illustrating how feedstock movements can restrain growth in market value.
Trade Remedies and Market Fragmentation
Trade measures introduced in 2025–2026 have fragmented what was previously a highly integrated global market. The European Union imposed definitive anti-dumping duties of 47.7% to 58.2% on Chinese lysine in July 2025, covering lysine hydrochloride, lysine sulphate and liquid lysine. The United States issued anti-dumping and countervailing duty orders on L-lysine from China, including lysine sulfate, effective 16 September 2026, and Brazil applied a definitive anti-dumping duty on Chinese lysine in June 2026. While these measures support producers inside the protected markets, they can raise feed costs, disrupt established supply contracts and redirect Chinese exports to other regions, increasing price pressure there.
Lower Concentration and Formulation Complexity
Because L-lysine sulfate contains less lysine per tonne than lysine hydrochloride, it incurs higher freight, storage and handling costs per unit of lysine, which can erode its price advantage in markets far from production sites. The product also contains sulphate and variable residual components, which nutritionists must account for in formulation, and some feed mills prefer the consistency of the hydrochloride form. When hydrochloride prices fall sharply, as the price of 98% lysine did in China in 2025, the cost gap narrows and some users switch back to the more concentrated form.
Realignment of Global Trade Flows
The combination of EU, U.S. and Brazilian duties on Chinese lysine is redirecting Chinese exports towards Southeast Asia, the Middle East, Africa and other markets without such measures. At the same time, producers in protected markets are reviewing capacity and pricing. This realignment is expected to persist through the forecast period and to widen regional price differences.
Capacity Concentration in China
China accounted for 79.6% of global lysine capacity in 2025, according to Chinese industry data, and global capacity grew by 15.4% in that year. Large producers continue to invest in scale and integration with corn processing, which lowers cost but intensifies price competition. Consolidation among Chinese producers, including Guangdong Xinghu Technology's acquisition of Eppen Biotech in 2022, is creating fewer, larger competitors.
Precision Nutrition and Digital Formulation
Feed producers are adopting precision nutrition tools, near-infrared analysis of raw materials and digestible amino acid formulation, which increases the precision with which lysine is supplied and supports the use of multiple amino acids. This trend favours suppliers that provide consistent product quality and technical support for formulation.
Animal Disease and Demand Volatility
Outbreaks of African swine fever and highly pathogenic avian influenza remain a key challenge. Herd losses and trade restrictions can abruptly reduce feed demand in affected countries, as China's swine sector experienced during the African swine fever epidemic. Such events make short-term demand for lysine sulfate volatile and complicate capacity planning.
The L-lysine sulfate value chain extends from agricultural feedstocks to livestock producers. Value is added mainly at the fermentation and finishing stages, where strain performance, yield and energy efficiency determine cost competitiveness.
Raw materials and inputs: corn and corn-derived dextrose or starch hydrolysates, cane or beet sugar and molasses serve as carbon sources; ammonia or ammonium sulphate supplies nitrogen; sulphuric acid, nutrients, process water and energy are additional inputs. Proprietary bacterial strains, typically Corynebacterium glutamicum, are a critical technological input.
Manufacturing: fermentation in large aerobic fermenters is followed by broth concentration, neutralisation with sulphate, and granulation or drying. Integrated producers often operate their own corn wet-milling facilities, capturing co-product value and reducing feedstock costs.
Distribution and channels: products are sold directly to large feed manufacturers and integrators under term contracts, or through distributors and traders that serve small and medium feed mills, premixers and importers. Packaging is typically in bags or bulk containers, and logistics cost per unit of lysine is an important consideration.
End users: compound feed manufacturers, premix and concentrate producers, integrated swine and poultry producers and on-farm feed mixers, who incorporate lysine sulfate into swine, poultry and other animal diets.
Feed additives, including L-lysine sulfate, are regulated through national and regional feed laws that cover product authorisation, labelling, safety and trade. The key frameworks in the major regions are outlined below.
2022: Guangdong Xinghu Technology; Acquisition; Completed the acquisition of Eppen Biotech, adding Eppen's lysine and amino acid operations; net profit rose to RMB 608 million in 2022, the first year after the acquisition.
Aug 2022: CJ CheilJedang; Expansion; Announced a USD 210 million investment to expand the lysine-producing amino acid plant of CJ do Brasil in Piracicaba, São Paulo, adding capacity for non-lysine amino acids.
Apr 2023: Evonik Industries; Restructuring; Announced measures to strengthen the competitiveness of its Animal Nutrition business line, including separate operating models for amino acids and specialties, about 200 job reductions and annual savings of EUR 200 million by 2025.
Jun 2023: Evonik Industries; Product launch; Launched an updated Biolys with 62.4% L-lysine content, up from 60%, produced in Blair, Nebraska, U.S., and Castro, Paraná, Brazil.
Jul 2024: Avril Group (Eurolysine); Acquisition; The French Commercial Court accepted Avril's bid, made with the Bpifrance-managed SPI fund, for the activities of Metex Nøøvistago; Eurolysine was formed with sites in Amiens and Saint-Beauzire.
Apr 2025: Eurolysine; Expansion; Launched a feasibility study to expand EU lysine production, under a EUR 130 million five-year investment plan targeting a 20% capacity increase by 2027.
Apr 2025: CJ CheilJedang; Strategy; Ended the sale process for its bio business, valued at about KRW 5 trillion, and decided to retain and expand the unit.
May 2025: CJ Bio America; Evonik Corp.; Trade action; As members of the Lysine Fair Trade Coalition, with ADM, filed anti-dumping and countervailing duty petitions on L-lysine from China with the U.S. Department of Commerce and the U.S. ITC.
Jul 2025: Meihua Holdings Group; Eppen; Trade measure; The EU imposed definitive anti-dumping duties on Chinese lysine, including lysine sulphate, of 47.7% for Meihua, 58.2% for Eppen and 53.1% for other cooperating companies, under Implementing Regulation (EU) 2025/1330.
2026: Fufeng Group; Expansion; Scheduled start of production at its Kazakhstan plant, targeting threonine and high-end amino acids for European markets.
Sep 2026: Meihua Holdings Group; Eppen; Fufeng Group; Trade measure; U.S. anti-dumping and countervailing duty orders on L-lysine from China, including lysine sulfate, took effect on 16 September 2026, with anti-dumping cash deposit rates from 73.37% to 139.65% and a countervailing duty rate of 48.21% for Inner Mongolia Eppen Biotech.
Political: Trade remedies in the EU (2025), the United States (2026) and Brazil (2026) have made trade policy a central factor in sourcing decisions. Food security policies in China and Saudi Arabia support domestic livestock production and, in China, reduced reliance on imported soybeans.
Economic: Lysine sulfate economics depend on corn, sugar and energy prices and on the relative price of soybean meal and lysine hydrochloride. Livestock profitability cycles, such as the pig cycle in China, influence feed demand and producers' willingness to pay for amino acids.
Social: Rising consumption of affordable animal protein in emerging economies drives feed demand, while consumer interest in sustainably produced meat encourages feed efficiency improvements.
Technological: Advances in strain engineering, fermentation yield and granulation technology are lowering costs and improving product concentration. Precision nutrition tools enable more accurate amino acid supplementation.
Environmental: Low-protein diets supplemented with lysine reduce nitrogen excretion and ammonia emissions from livestock. Producers face scrutiny over the energy use, water consumption and carbon footprint of fermentation plants.
Legal: Feed additive authorisation, labelling and safety rules in each market, as well as anti-dumping and countervailing duty proceedings, shape market access and compliance costs.
Profiles of 29 companies operating in the L-Lysine Sulfate Market market, including revenue, employee count, and market positioning where available.
Showing 29 of 29 companies
Evonik is Germany's second-largest listed chemicals group after BASF and one of Europe's broadest pure-play specialty chemicals companies, generating €14.1bn of sales and €1.87bn adjusted EBITDA in FY2025. Since April 2025 it has been organised into two operating segments — Custom Solutions (formulated, application-driven specialties for coatings, personal care, pharma, and industrial additives) and Advanced Technologies (scale- and technology-driven platforms in silica, hydrogen peroxide, high-performance polymers, crosslinkers and animal-nutrition amino acids) — plus an Infrastructure segment (SYNEQT site services, Oxeno C4 chemicals) earmarked for divestment. Its competitive identity rests on deep process know-how, integrated German Verbund sites (Marl, Wesseling, Rheinfelden, Essen, Hanau), and leadership positions in global niches (fumed silica, DL-methionine, PA12, pharma excipients/lipids). The investment case is a transformation story — €400m-plus cost reduction, portfolio pruning, deleveraging — now overlaid by a live takeover approach from BASF and a near-majority foundation shareholder whose stance is pivotal. --- ### Company self-description Evonik describes itself as a global chemical company that goes "beyond chemistry" by combining innovative strength with leading technological expertise, providing customers with a competitive advantage through tailor-made products and solutions — positioning itself as a "superforce for industry" (company boilerplate, press releases 2026; Company Factbook 2026). Its stated strategic pillars (Capital Markets Day, 22 May 2025) are: a differentiated portfolio in two segments, sustainable innovation, a balanced regional footprint (ambition of roughly one-third of sales in each of Americas, EMEA and Asia-Pacific), and a performance culture. ### Independent characterisation Evonik is a mid-cap, diversified specialty and "semi-specialty" chemicals manufacturer. Roughly 80% of FY2025 sales (€11.5bn of €14.1bn) came from the two core segments; the remaining ~18–19% came from Infrastructure & Other, which bundles low-margin site services and the cyclical C4 (Oxeno) petrochemical chain. The business is overwhelmingly a product business (manufactured chemicals sold B2B under supply contracts, frame agreements and spot), with smaller service/contract components: (i) pharma CDMO and contract manufacturing (Health Care — lipids/LNPs, drug substances, oral drug delivery), (ii) site infrastructure and utility services sold by SYNEQT to ~two dozen third-party companies in the Marl and Wesseling chemical parks, and (iii) licensing/technology (e.g., HPPO hydrogen peroxide technology with partners; catalysts). Subscription revenue is negligible. Precise revenue-model split (product vs service vs licensing) is n/d. ### Value-chain position Evonik sits mid-stream: it buys petrochemical feedstocks (C4 raffinate, propylene, methanol, ammonia, natural gas/energy, silicon metal, sulphur) and converts them into intermediates and formulated specialties sold to formulators and OEMs. Upstream integration is partial (own C4 cracking downstream of refinery/cracker streams at Marl and Antwerp; own HCN and methionine chain in Antwerp, Mobile and Singapore). Downstream, it rarely sells to consumers; its products are ingredients typically <5% of the customer's cost but critical to performance ("small cost share, high value-in-use"), which supports pricing power in the specialty businesses. ### Customer types and end markets Customers include paint and coatings formulators, adhesives and sealants makers, tyre and rubber producers (silica/silanes), cosmetic and household-care brands, pharmaceutical and biotech companies (excipients, lipids, CDMO), animal-feed mills and integrators (methionine), plastics and automotive suppliers (PA12, PEEK), aerospace (ROHACELL foams), pulp & paper, electronics and semiconductors (high-purity silanes/chlorosilanes, H2O2), renewable energy and hydrogen (membranes, catalysts), and biodiesel producers (alkoxide catalysts). End-market exposure is broad: consumer/personal care, health care, food/feed, automotive and mobility, construction, coatings, industrial, energy/agriculture. A precise end-market % split for FY2025 is n/d in sources reviewed.
Company Headquarters: Shandong, China Founded: 2004 Workforce: ~ 3000 Company Working: Zhucheng Dongxiao Biotechnology is a starch sugar manufacturer with total sales in five continents. The company offers various corn starch sugar (alcohol), organic acids, milk-based powder, amino acids, and other products. The company has also passed ISO09001 quality management system, ISO14001 environmental management system, ISO22000 food safety management system, HACCP system, and many more domestic and foreign quality certification and had won the national high-tech enterprise, national agricultural industrialization key leader enterprise, Green Factory of the Ministry of industry and information technology of the people’s republic of China, and many more awards and recognitions.
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
Nippon Soda is a mid-cap, diversified Japanese chemical group founded in 1920 as a chlor-alkali producer and progressively re-shaped into a portfolio anchored by two high-value franchises: research-based crop protection (Agri Business, 35% of FY3/26 sales) and specialty "Chemical Materials" (25%), complemented by lower-margin but stable trading/logistics, plant engineering and environmental-recycling businesses. Its crown jewels are niche, high-barrier products in which it holds globally relevant positions — the pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose), liquid polybutadiene NISSO-PB for AI-server copper-clad laminates, KrF photoresist polymer VP-POLYMER, and proprietary agrochemicals such as Mospilan (acetamiprid) and Topsin-M. With FY3/26 net sales of JPY 152.1 billion, record net profit of JPY 18.3 billion, an equity ratio of ~66.6%, and a 50%+ total shareholder return policy, the company is a conservatively financed, R&D-led specialty player now pivoting toward healthcare (including animal health) and advanced ICT materials under its Stage III plan to FY3/30. --- ### Company's own description According to its Stage III medium-term plan (May 2026), Nippon Soda describes its mission as creating new value through the power of chemistry, and frames the group as supporting everyday life through chemical products and services across four "material" fields: Agriculture (securing food and sustainable agriculture), Healthcare (healthy life for all people), Environment (toward a resource-recycling society) and ICT (chemical functions for IT devices). The Yuho describes the parent's business as manufacturing, processing and marketing of industrial chemicals, synthetic resins and plastics, dyes, pharmaceuticals, agrochemicals, veterinary pharmaceuticals and other chemical products. ### Business model and revenue model Nippon Soda's revenue is overwhelmingly product-based (manufactured chemical sales), with secondary service revenues from logistics (warehousing, transport, customs brokerage), engineering/EPC contracts and waste treatment. There is no material subscription revenue. Licensing/active-ingredient supply is embedded in Agri Business: the company supplies proprietary active ingredients (AIs) to global majors and sells formulated products through its own overseas network and partners. The revenue mix by nature (approximation from FY3/26 segment data; company does not disclose a product/service split): *Note: the above split is an analytical characterization; the company does not report revenue by nature.* ### Value-chain position **Agri Business:** fully integrated R&D-type agrochemical originator — chemical synthesis, biological/safety research, formulation research, field evaluation, AI manufacturing (including via Nisso Namhae Agro in Korea) and formulation, registration and global marketing (Stage III plan). The company emphasizes that R&D-type agrochemical originators are largely limited to five overseas majors plus Japanese firms, and that Japanese originators punch above their weight in new AI discovery. **Chemical Materials:** upstream chlor-alkali (caustic soda, chlorine, hydrochloric acid) feeding downstream fine/specialty chemistry (living anionic polymerization for NISSO-PB and VP-POLYMER; cellulose derivatization for HPC; penem API synthesis). **Trading & Logistics:** captive and third-party distribution (Nisso Shoji) and specialized hazardous/pharma logistics (Sanwa Soko, Sanso Unyu). **Engineering:** fine-chemical-type EPC (Nisso Engineering) and civil works (Nisso Kensetsu). **Eco Solutions:** waste treatment, zinc recovery from electric-arc-furnace dust, sulfuric acid recycling (Nisso Metallochemical). ### Customer types and end-markets Customers include global agrochemical majors and distributors, farmers' cooperatives (via channels), generic and innovator pharmaceutical companies and supplement makers (HPC, SSF, faropenem API), copper-clad-laminate (CCL) and semiconductor-materials producers (NISSO-PB, 1,2-SBS, VP-POLYMER), thermal-paper manufacturers (color developers), battery-materials producers, industrial users of commodity chemicals, steelmakers (EAF dust treatment), and public/private construction clients (Engineering). End-markets: crop protection (fruit & vegetables first, expanding to grains), pharmaceuticals/nutraceuticals, semiconductors/electronics (AI servers, HBM, automotive chips), infrastructure, and environmental services. ### Independent characterization Nippon Soda is best understood as two engines and three stabilizers. The engines — Agri Business and specialty Chemical Materials — generated roughly 75% of FY3/26 segment operating profit (JPY 11.2 billion of JPY 14.97 billion before adjustments) on 60% of sales. Agri is cyclical and FX-sensitive (65.7% overseas sales ratio in FY3/26), while Chemical Materials has been structurally re-rated from a ~5–6% margin business to ~15–17% after exiting commodity lines (metallic sodium via Alkaline S.A.S., NISSO HI-CHLON, phenol-based color developers, sodium cyanide). The stabilizers (Trading & Logistics, Engineering, Eco Solutions) are low-growth and modest-margin but add scale and cash. A further, often-overlooked profit pillar is equity-method income (JPY 6.06 billion in FY3/26, chiefly Iharabras in Brazil), which made ordinary profit (JPY 22.99 billion) much larger than operating profit and is highly FX-sensitive (BRL/USD).
RPM International is a holding company for more than a dozen semi-autonomous specialty-chemicals franchises. These businesses make coatings, sealants, roofing, concrete admixtures, flooring, fireproofing and building-envelope systems, mostly for maintenance, repair and restoration rather than new construction. Its brand portfolio is unusually deep for a USD 7.9 billion company: Rust-Oleum, DAP, Zinsser, Varathane and The Pink Stuff on the consumer side; Tremco, Euclid, Dryvit, Nudura, Kalzip, Stonhard, Carboline and Fibergrate on the professional side. Each brand holds a leading position in a niche that larger diversified coatings groups do not dominate. Since 2018 RPM has run successive operational-improvement programs (MAP to Growth, MAP 2025, and now "MAP 3.0"). These have lifted gross margin from about 36% (FY2022) to about 41% (FY2026) and moved the group from a loose federation toward a centrally coordinated operating company. RPM is a disciplined, dividend-growing compounder with 52 consecutive annual dividend increases. Its growth vectors are engineered building systems, emerging markets (the "Platform" model) and bolt-on M&A. --- ### Company's own description (FY2026 Form 10-K, Item 1) RPM describes itself as follows: its subsidiaries manufacture, market and sell specialty chemical product lines, including high-quality specialty paints, infrastructure rehab and repair products, protective coatings, roofing systems, sealants and adhesives. These products focus on the maintenance and improvement needs of the construction, industrial, specialty and consumer markets. Footprint as of 31 May 2026: - Products marketed in about 167 countries and territories. - Manufacturing in about 120 locations across 22 countries. - About 31% of sales generated internationally: foreign operations 29.8% of net sales, plus direct U.S. exports of 0.9%. The press-release boilerplate calls RPM "a world leader in specialty coatings, sealants, building materials and related services." ### Business model RPM's model has four defining features. - **Decentralised entrepreneurial structure, becoming more integrated.** The founder's philosophy, still quoted in the 2026 proxy, is: "Hire the best people you can find. Create an atmosphere that will keep them. Then let them do their jobs." Operating companies historically kept their own brands, sales forces and ERP systems. The MAP programs are deliberately centralising procurement, manufacturing, accounting and IT. The stated goal is to consolidate more than 75 ERP systems to one platform per segment (Q4 FY2026 8-K). **Repair and maintenance bias:** Much of the portfolio serves existing assets: roof restoration, re-cover, concrete repair, corrosion control, rust prevention and DIY touch-up. That demand is less cyclical than new-build construction. The FY2026 10-K notes that re-roofing has historically accounted for over three-quarters of U.S. roofing demand. **Systems and turnkey selling:** In CPG and PCG, RPM increasingly sells integrated systems (the "Power of One" building envelope) and supply-and-apply turnkey services. Examples include Stonhard flooring installation and Weatherproofing Technologies roofing services. This captures more of each construction project's spend. **Bolt-on M&A plus organic growth:** RPM completed six acquisitions in each of FY2025 and FY2026 (FY2026 10-K Note F). ### Revenue model mix | Revenue type | Characterisation | Evidence | |---|---|---| | Product sales | Dominant (estimated well above 90% of revenue; exact split not publicly disclosed) | Manufactured coatings, sealants, admixtures and similar products sold through retail, distribution and direct channels | | Installation and services | Material within CPG and PCG; not separately disclosed | WTI/WTC roofing services, turnkey general contracting, TremCare maintenance programs, Stonhard installed flooring, Legend Brands/RoofTec restoration services, Pure Air Control Services | | Warranty and extended programs | Embedded in pricing; generates deferred revenue | Current unearned revenue USD 75.3M and long-term unearned revenue USD 92.4M at FY2026 (standardized balance sheet) | | Licensing and royalties | Minor | The 10-K notes license fees and royalty income from numerous international license agreements, plus equity-method joint ventures | | Subscription | None identified | — | RPM does not disclose a product versus service versus licensing split. From filings, the mix is: ### Value-chain position RPM is a formulator and brand owner, positioned downstream of commodity chemical producers. It buys petroleum-derived resins, solvents, pigments, minerals, metals and packaging (FY2026 10-K, Raw Materials). It is selectively backward-integrated: RPM cites expanding in-house raw material production, and Arnette Polymers makes amine curing agents and epoxy intermediates. Channels downstream include: - Mass merchants and home centres, where the single largest Consumer customer was 20% of Consumer sales in FY2026. - Hardware and paint stores. - Distributors. - Contractors and specifiers. - Direct sales to industrial plant owners, public institutions and infrastructure agencies. ### Customer types and end markets | End market | Segment exposure | Representative brands | |---|---|---| | Commercial / institutional building envelope (roofing, walls, waterproofing, sealants) | CPG | Tremco, Dryvit, Nudura, illbruck, Kalzip, Volteco | | Concrete, cement and infrastructure | CPG, PCG | Euclid, Toxement, Viapol, Prime Resins, Fibrecrete | | Industrial maintenance, oil and gas, petrochemical, power, data centres | PCG | Carboline, Stonhard, Fibergrate, Nullifire | | Food and pharma | PCG | Mantrose-Haeuser, NatureSeal, Profile Food Ingredients | | Marine, wood finishes, powder coatings | PCG | Pettit, Woolsey, FinishWorks/Mohawk, TCI | | Residential DIY and professional painters | Consumer | Rust-Oleum, Zinsser, Varathane, DAP | | Household cleaning | Consumer | The Pink Stuff, Krud Kutter, Mean Green | | Pigments, colorants, OEM and personal care | Consumer (Color Group) | Day-Glo | | Restoration services equipment | CPG (Legend Brands) | Dri-Eaz, Sapphire Scientific | ### Independent characterisation RPM is best understood as a portfolio of niche category leaders with a structural margin-improvement story layered on top. The professional segments (CPG and PCG) are about 66% of sales and supply the growth. In FY2026 they posted record results driven by high-performance buildings, data centres, infrastructure, fireproofing and concrete admixtures. In Q1 FY2027, emerging-market regions grew more than 20%. The Consumer segment is about 34% of sales. It is a cash-generative but volume-challenged DIY business. Organic Consumer sales fell 0.8% in Q4 FY2026 and 4.7% in Q2 FY2026. They recovered to +5.2% in Q1 FY2027 on shelf-space wins and pricing. The equity debate therefore centres on three questions: 1. Can MAP savings and pricing protect margins against renewed raw-material inflation linked to the Middle East conflict? 2. Is the Q1 FY2027 CPG slowdown temporary? 3. Will the 9 November 2026 investor day credibly frame the next margin plan?
Company Headquarters: Amsterdam, Netherlands Founded: 1994 Workforce: ~35,200 Company Working: Akzo Nobel N.V. operates its business by manufacturing products of various industries such as decorative paints, automotive & specialty coatings, industrial coatings, powder coating and marine, protective and yacht coatings. The automotive and specialty coatings segment of the business comprises products such as aerospace coatings, consumer electronics coatings, automotive OEM coatings, vehicle refinishes and sign finishes. Further, its industrial coatings segment offers products including coil and extrusion coatings, wood finishes, packaging coatings, and adhesives. The company owns more than 3,100 patents and has robust research and development capabilities which is evident from the fact that it has spent around USD 1.33 billion on research and development in last five years and possess five R&D centers. The brand portfolio offered by the company includes Dulux, Sikkens, International and Interpon and has a strong geographical presence in around 150 countries.
108 interactive charts drawn from the L-Lysine Sulfate Market dataset — market size, each segment breakdown, and every region and country by segment. Open one to read its full data table and download it.
Global L-Lysine Sulfate Market By Region
Global L-Lysine Sulfate Market By Livestock
Global L-Lysine Sulfate Market By Physical Form
Global L-Lysine Sulfate Market — North America by Country
Global L-Lysine Sulfate Market — North America by Livestock — Market Value
Global L-Lysine Sulfate Market — North America by Physical Form — Market Value
Global L-Lysine Sulfate Market — U.S. by Livestock — Market Value
Global L-Lysine Sulfate Market — U.S. by Physical Form — Market Value
Global L-Lysine Sulfate Market — Canada by Livestock — Market Value
Global L-Lysine Sulfate Market — Canada by Physical Form — Market Value
Global L-Lysine Sulfate Market — Mexico by Livestock — Market Value
Global L-Lysine Sulfate Market — Mexico by Physical Form — Market Value
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and forecast (2022–2032, USD Million)
Market Size (USD Million)
